AMPEL BioSolutions

Charlottesville, United States

AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.

Jul 2023

Debt Financing

Biotechnology Health Care Health Diagnostics Precision Medicine

Top Investors

U.S. Small Business Administration

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AMPEL BioSolutions

Who are AMPEL BioSolutions's investors?

AMPEL BioSolutions's investors include U.S. Small Business Administration.

Where is AMPEL BioSolutions headquartered?

AMPEL BioSolutions is headquartered in Charlottesville, United States.

What does AMPEL BioSolutions do?

AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.

What stage is AMPEL BioSolutions at?

AMPEL BioSolutions is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 6, 2023.

MLA

"AMPEL BioSolutions — Funding & Investors." VCBacked, July 6, 2023, https://www.vcbacked.co/company/ampel-biosolutions. Accessed July 1, 2026.

APA

VCBacked. (2023). AMPEL BioSolutions — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/ampel-biosolutions

Wikipedia (cite web)

{{cite web |title=AMPEL BioSolutions — Funding & Investors |url=https://www.vcbacked.co/company/ampel-biosolutions |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 6, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.